For a few steps to..., or how to avoid for iron deficiency at pregnancy
DOI:
https://doi.org/10.37800/RM2020-1-20Keywords:
iron deficiency anemia, anemia of chronic disease, iron deficiency, obstetric and perinatal complications, prevention, pregravid preparation, liposomal iron, FerroviewAbstract
The article presents modern data on the etiology, pathogenesis, diagnosis, prevention and treatment of iron deficiency anemia (IDA) and anemia of chronic disease, as well as their combination on the eve of and during pregnancy. The emphasis is made on the role of iron deficiency of any etiology in the development of obstetric and perinatal complications, especially its impact on the central nervous system formation and further psychophysical child development. Need for prevention of iron deficiency states in risk groups which includes all women of reproductive age who have menstruation is shown based on evidence-based
medicine data. Effectiveness and safety of modern drugs containing iron in oral and parenteral forms has analyzed. The paper presents data on the safety and effectiveness of an innovative form of ferric iron in the form of liposomal iron, which differs in the mechanism of action, digestibility and the absence of side effects typical for this group of drugs. According to various authors the frequency of IDA in pregnant women ranges up to 80%, in puerperas up to 40%. It is unimpossible to stop IDA without iron supplementation only with an iron-rich diet. Two main groups of iron preparations are used to correct iron deficiency differing in the valence of iron atoms – bivalent iron salts and trivalent complexes. These drugs differ in the tolerability and bioavailability of atomic iron. Liposomal iron is a new drug for treatment of iron deficiency and IDA today; it has an innovative way of iron delivery to the body. Liposomal iron has advantages for the prevention of anemia in patients with anemia of chronic disease or its combination with IDA (inflammatory bowel diseases, obesity, after resection of the stomach and intestines, etc.). An innovative form of liposomal iron in Ukraine is represented by a dietary supplement Ferroview containing 30 mg of elemental iron, that is corresponds to the average prophylactic dose recommended in WHO documents.
References
Анемии: железодефицитная, В12-дефицитная и анемия хронических заболеваний: Информационное письмо для врачей-гематологов, терапевтов, врачей-интернов и врачей-ординаторов. Ростов-на-Дону, 2013. 20 с.
Анемии и репродуктивное здоровье. А.В. Соловьева, В.Г. Стуров и соавт. / под ред. В.Е. Радзинского. М. Редакция журнала StatusPraesens, 2019. 200 c.
Бриль Ю.А. Превентивные и лечебные стратегии при железодефицитных состояниях в практике акушера-гинеколога // StatusPraesens. Гинекология, акушерство, бесплодный брак. 2017. № 3 (39). С. 79-88.
Вялов С.С. Эффективность и безопасность липосомального железа в лечении анемии после резекции желудка или кишечника // Клин. фармакол. тер., 2016, 25 (4), 42-46.
Гопчук О.М. Залізодефіцитна анемія // Здоровье женщины. 2019. № 9 (145). С. 32-37.
Жабченко И.А. Анемия в послеродовом периоде // Труды Крымского государственного медицинского университета им. С.И. Георгиевского «Проблемы, достижения и перспективы развития медико-биологических наук и практического здравоохранения». 2008. Т.144, Ч. ІІІ. С. 121-125.
Логутова Л.С. Анемия у беременных: вопросы этиологии, диагностики и лечения // РМЖ. 2016. № 5. С. 290-293.
Медведь В.І., Кирильчук М.Є. Профілактика залізодефіциту та анемії у вагітних // Жіночий лікар. 2019. № 4 (84). С. 28-30.
Радзинский В.Е., Князев С.А., Костин И.Н. Акушерский риск. М.: Эксмо. 2009. 288 с.
Радзинский В.Е. Не мистика, а тайны мудрости // StatusPraesens. 2019. № 2 (55). С. 7-9.
Рукавицын О.А. Анемия хронических заболеваний: отдельные аспекты патогенеза и пути коррекции // Онкогематология. 2016. Т.11, № 1. С. 37-46.
Старший репродуктивный возраст: контрацепция и не только. Рациональная контрацепция женщин старшего возраста: контрацептивные и неконтрацептивные аспекты. Информационный бюллетень / Т.С. Рябинкина, Х.Ю. Симоновская, О.Д. Руднева; под ред. В.Е. Радзинского. — М.: Редакция журнала StatusPraesens, 2014. — 16 с.
Стуклов Н.И., Козинец Г.И., Леваков С.А. и др. Анемии при гинекологических и онкогинекологических заболеваниях. М.: МИА, 2013. 238.с.
Стуклов Н.И. Ферродефицитные синдромы в вопросах и ответах // StatusPraesens. 2017. № 5 (42). С. 120-124.
Стуклов Н.И., Князев О.В., Парфенов А.И., Басиладзе И.Г., Пивник А.В. Сравнительная эффективность применения новой сукросомальной формы железа для перорального приёма и внутривенной ферротерапии в лечении анемий у больных воспалительными заболеваниями кишечника // Клин. мед. 2017; 95 (12): 1112—1117.
Федорова Т.А., Борзыкина О.М., Бакуридзе Э.М. и др. Коррекция железодефицитной анемии у пациенток с гинекологическими заболеваниями с использованием липосомального железа // Гинекология. 2017; 19 (1): 68–72.
Ших Е.В., Бриль Ю.А. Железодефицит: катастрофа для нейрогенеза // StatusPraesens. 2018. № 10. С. 82-88.
Abu-Our N.M., Ja M.M. The impact of maternal iron deficiency and iron deficiency anemia on child’s health // Saudi Med. J. 2015. Vol. 36. № 2. Р. 146-149. [PMID: 4375689].
Amstad Bencaiova G., Krafft A., Zimmermann R., Burkhardt N. Treatment of anemia of chronic disease with true iron deficiency in pregnancy // J. Pregnancy. 2017. Vol. 2017. Art. № 4265091. 7 р. [PMID: 29348938].
Auerbach M, Ballard H. Clinical use of intravenous iron: administration, efficacy, and safety. Hematology Am Soc Hematol Educ Program 2010; 2010:338.
Bircher AJ, Auerbach M. Hypersensitivity from intravenous iron products. Immunol Allergy Clin N Am 2014; 34:707.
Boggs DR. Fate of a ferrous sulfate prescription. Am J Med 1987; 82:124.
Breymann C., Xu-ming B., Blanco-Capito L.R. et al. Expert recommendation for the diagnosis and treatment of iron deficiency anemia during pregnancy and the postpartum period in the Asia-Pacific region // J. Perinatal Medicine.2011. Vol. 39. № 2. Р.113-121. [PMID: 21870128].
Cancelo-Hidalgo MJ, Castelo-Blanco C, Palacios S, et al. Tolerability of different oral iron supplements: a systematic review. Curr Med Res Opin 2013; 29:291.
Giordano G, Mondello P, Tambaro R et al. Intravenous iron support vs oral liposomal iron support in patients with refractory anemia treated with Epo alpha. Monocentric prospective study. Leukemia Res 2011;35: S137.
Giordano G, Mondello P, Tambaro R et al. Biosimilar erythropoietin alpha is effective as originator erythropoietin alpha plus liposomial iron and B12 and folates in patients with refractory anemia: A retrospective real-life approach. Blood 2014;124(21):4880.
Goddard AF, James MW, McIntyre AS, et al. Guidelines for the management of iron deficiency anaemia. Gut 2011; 60:1309.
Daily iron supplementation in adult women and adolescent girls: Guideline. Geneva: WHO, 2016.
Donker AE, Raymakers RA, Vlasveld LT, et al. Practice guidelines for the diagnosis and management of microcytic anemias due to genetic disorders of iron metabolism or hem synthesis. Blood 2014; 123:3873.
Khalafallah A, Dennis A, Bates J, et al. A prospective randomized, controlled trial of intravenous versus oral iron for moderate iron deficiency anaemia of pregnancy. J Intern Med 2010; 268:286.
Lozano R., Foreman K. et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: A systematic analysis for the Global burden of disease study 2010 // Lancet Glob. Health. 2013. Vol. 380. H. 2095-2128. [PMID: 23245604].
Okam MM, Mandell E, Hevelone N, et al. Comparative rates of adverse events with different formulations of intravenous iron. Am J Hematol 2012;87: E123.
Pregnancy and Obstetrical Outcomes in Women Over 40 Years of Age Schwangerschaft und Geburt bei Frauen über 40 / Jahre A., Dietl S., Cupisti M. et al. // Zollner Geburtshilfe Frauenheilkd. 2015. № 75 (08). Р. 827-832.
Scott S.P., Chen-Edinboro L.P., Caulfield L.E., Murray-Kolb L.E. The impact of anemia on child mortality: An updated review // Nutrients. 2014. Vol. 6. № 12. Р. 5915-5932. [PMID: 4277007].
Tandu-Umba B., Mbangma A.M. Association of maternal anemia with order risk factors in occurrence of Great obstetrical syndromes at university clinics, Kinshasa, DR Congo // BMC Pregnancy Childbirth. 2015. Vol. 15. Р. 183. [PMID: 26292718].
Tarantino G. New delivery system for high bioavailable iron supplements. Nutrafoods 2013; 12:71-8.
Tracking Universal Health Coverage: 2017 Global Monitoring Report. 2017. WHO and the International Bank for Reconstruction and Development. 88.
Weiss G., Goodnough L.T. Anemia of inflammation // Blood. 2019. Vol. 133. № 1. Р. 40-50. Review. [PMID: 30401705].
WHO recommendations on antenatal care for a positive pregnancy experience. Женева: ВОЗ; 2017 г.
Additional Files
Published
How to Cite
Issue
Section
License
The articles published in this Journal are licensed under the CC BY-NC-ND 4.0 (Creative Commons Attribution – Non-Commercial – No Derivatives 4.0 International) license, which provides for their non-commercial use only. Under this license, users have the right to copy and distribute the material in copyright but are not permitted to modify or use it for commercial purposes. Full details on the licensing are available at https://creativecommons.org/licenses/by-nc-nd/4.0/.
